PubRank

D Franchimont

Author PubWeight™ 21.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998 2.20
2 Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 2008 2.01
3 A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1997 1.85
4 Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 2004 1.62
5 The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007 1.50
6 Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000 1.30
7 Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis. J Crohns Colitis 2011 1.18
8 Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000 1.06
9 Anticipation in familial Crohn's disease. Gut 1998 1.04
10 Profile of soluble cytokine receptors in Crohn's disease. Gut 2005 0.97
11 Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. Ann Oncol 2011 0.91
12 L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation. Clin Exp Immunol 2009 0.88
13 Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999 0.83
14 An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol 2009 0.82
15 [Treatment of colorectal cancer: a resolute multidisciplinary approach]. Rev Med Brux 2001 0.79
16 [Screening for colorectal cancer by endoscopy: rectosigmoidoscopy or coloscopy?]. Rev Med Brux 2001 0.77
17 Review and clinical perspectives for the use of infliximab in ulcerative colitis. Can J Gastroenterol 2008 0.77
18 Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I molecules. J Neuroimmunol 1997 0.76
19 Familial adenomatous polyposis: clinical presentation, detection and surveillance. Acta Gastroenterol Belg 2011 0.76
20 [Organized colorectal screening in French Community of Belgium and polyp surveillance]. Rev Med Brux 2009 0.75
21 [Current contribution of genetics in intestinal inflammatory diseases]. Acta Clin Belg 1993 0.75
22 [Crohn's disease]. Rev Med Brux 2002 0.75
23 Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD). Acta Gastroenterol Belg 2015 0.75
24 Thymic neuroendocrine self-antigens. Role in T-cell development and central T-cell self-tolerance. Ann N Y Acad Sci 2000 0.75
25 Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. Int Arch Allergy Immunol 1996 0.75
26 Systemic immune response after rectocolonic administration of ovalbumin in mice. Int Arch Allergy Immunol 1995 0.75
27 FAPA--familial adenomatous polyposis association the Belgian Polyposis Registry. Acta Gastroenterol Belg 2011 0.75
28 Cellular and molecular aspects of thymic T-cell education in neuroendocrine self principles. Implications for autoimmunity. Ann N Y Acad Sci 1998 0.75
29 Gastric endometriosis associated with transverse colon endometriosis: a case report of a very rare event. Arch Gynecol Obstet 2014 0.75
30 Glucocorticoid-inducible genes that regulate T-cell function. Ernst Schering Res Found Workshop 2002 0.75
31 [Individual screening for colorectal cancer: which strategy for which patient?]. Rev Med Brux 2001 0.75
32 [The medical gastroenterology department]. Rev Med Brux 2002 0.75